動(dòng)脈粥樣硬化匯集了所有來(lái)源的有關(guān)動(dòng)脈粥樣硬化及其并發(fā)癥和相關(guān)疾病的研究和調(diào)查的論文，包括：脂蛋白代謝、動(dòng)脈和血管生物學(xué)和疾病、血栓形成、炎癥、脂質(zhì)轉(zhuǎn)運(yùn)障礙、糖尿病和高血壓與動(dòng)脈粥樣硬化有關(guān)，心血管危險(xiǎn)因素。編輯們還對(duì)涉及特定或一般興趣的病例研究、新的或不尋常的脂質(zhì)綜合征、動(dòng)脈粥樣硬化和相關(guān)疾病的遺傳基礎(chǔ)和家族發(fā)病率的臨床論文感興趣。如果本文討論藥物或飲食的作用機(jī)制，將考慮對(duì)藥物或飲食的控制性臨床試驗(yàn)的高質(zhì)量報(bào)告。歐洲動(dòng)脈粥樣硬化學(xué)會(huì)和國(guó)際動(dòng)脈粥樣硬化學(xué)會(huì)的所有成員都可獲得降低的個(gè)人訂閱率。動(dòng)脈粥樣硬化沒(méi)有頁(yè)面費(fèi)用。請(qǐng)向出版商申請(qǐng)更多信息。

Atherosclerosis brings together from all sources papers concerned with research and investigation on atherosclerosis, its complications, and related diseases, including: lipoprotein metabolism, arterial and vascular biology and disease, thrombosis, inflammation, disorders of lipid transport, diabetes and hypertension as related to atherosclerosis, and cardiovascular risk factors. The editors are also interested in clinical papers dealing with case studies of specific or general interest, new or unusual lipid syndromes, and the genetic basis and familial incidence of atherosclerosis and related diseases. High quality reports of controlled clinical trials of drugs or diets will be considered provided the paper deals with the mechanism of action of the drug or diet.A reduced personal subscription rate is available to all members of the European Atherosclerosis Society and the International Atherosclerosis Society. Atherosclerosis has no page charges. Please apply to the Publisher for more information.